DrugPatentWatch Database Preview

DAURISMO Drug Profile

« Back to Dashboard

Which patents cover Daurismo, and what generic alternatives are available?

Daurismo is a drug marketed by Pfizer Inc and is included in one NDA. There are two patents protecting this drug.

This drug has forty-nine patent family members in forty-one countries.

The generic ingredient in DAURISMO is glasdegib maleate. One supplier is listed for this compound. Additional details are available on the glasdegib maleate profile page.

Summary for DAURISMO

International Patents:	49
US Patents:	2
Applicants:	1
NDAs:	1
Suppliers / Packagers:	1
Prior Art and Litigation Support	Order Prior Art and Litigation support for DAURISMO
DailyMed Link:	DAURISMO at DailyMed

Generic Entry Opportunity Date for DAURISMO

Constraining patent/regulatory exclusivity:

INDICATED, IN COMBINATION WITH LOW-DOSE CYTARABINE, FOR THE TREATMENT OF NEWLY-DIAGNOSED ACUTE MYELOID LEUKEMIA (AML) IN ADULT PATIENTS WHO ARE >=75 YEARS OLD OR WHO HAVE COMORBIDITIES THAT PRECLUDE USE OF INTENSIVE INDUCTION CHEMOTHERAPY

NDA:

210656

Dosage:

TABLET;ORAL

^*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

US Patents and Regulatory Information for DAURISMO

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pfizer Inc	DAURISMO	glasdegib maleate	TABLET;ORAL	210656-001	Nov 21, 2018		RX	Yes	No			Y
Pfizer Inc	DAURISMO	glasdegib maleate	TABLET;ORAL	210656-002	Nov 21, 2018		RX	Yes	Yes
Pfizer Inc	DAURISMO	glasdegib maleate	TABLET;ORAL	210656-001	Nov 21, 2018		RX	Yes	No
Pfizer Inc	DAURISMO	glasdegib maleate	TABLET;ORAL	210656-002	Nov 21, 2018		RX	Yes	Yes
Pfizer Inc	DAURISMO	glasdegib maleate	TABLET;ORAL	210656-001	Nov 21, 2018		RX	Yes	No			Y	Y

International Patents for DAURISMO

Country	Patent Number	Estimated Expiration
Israel	202420
Spain	2609258
South Korea	20100028120
Cyprus	1118650
Taiwan	200911792